TNFRSF11A and cancer: In this regard, we recently identified a receptor activator of nuclear-factor–κB (RANK)-positive CTC in bone metastatic BCa patients, suggesting that RANK expression may represent a phenotypic and biologic property of cancer cells with elevated osteotropism (34).